Detailed information for compound 1429059

Basic information

Technical information
  • TDR Targets ID: 1429059
  • Name: propan-2-yl 5'-acetyl-2'-amino-6'-methyl-2-ox ospiro[1H-indole-3,4'-pyran]-3'-carboxylate
  • MW: 356.373 | Formula: C19H20N2O5
  • H donors: 2 H acceptors: 3 LogP: 1.53 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(OC(=O)C1=C(N)OC(=C(C21C(=O)Nc1c2cccc1)C(=O)C)C)C
  • InChi: 1S/C19H20N2O5/c1-9(2)25-17(23)15-16(20)26-11(4)14(10(3)22)19(15)12-7-5-6-8-13(12)21-18(19)24/h5-9H,20H2,1-4H3,(H,21,24)
  • InChiKey: FAIVZCRUPGPMRK-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • isopropyl 5'-acetyl-2'-amino-6'-methyl-2-oxo-spiro[indoline-3,4'-pyran]-3'-carboxylate
  • 5'-acetyl-2'-amino-6'-methyl-2-oxo-3'-spiro[indoline-3,4'-pyran]carboxylic acid isopropyl ester
  • 5'-acetyl-2'-amino-2-keto-6'-methyl-spiro[indoline-3,4'-pyran]-3'-carboxylic acid isopropyl ester
  • propan-2-yl 2'-amino-5'-ethanoyl-6'-methyl-2-oxo-spiro[1H-indole-3,4'-pyran]-3'-carboxylate
  • BAS 06900481
  • MLS000050660
  • ST071534
  • isopropyl 5'-acetyl-2'-amino-6'-methyl-2-oxo-1,2-dihydrospiro[indole-3,4'-pyran]-3'-carboxylate
  • SMR000078111

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ubiquitin specific peptidase 1 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi Zn-finger in Ran binding protein and others, putative 0.0037 0 0.5
Loa Loa (eye worm) SWIB/MDM2 domain-containing protein 0.0104 1 1
Echinococcus granulosus Upstream activation factor subunit UAF30 0.0104 1 1
Schistosoma mansoni hypothetical protein 0.0104 1 1
Schistosoma mansoni hypothetical protein 0.0104 1 1
Echinococcus multilocularis SWI:SNF matrix associated 0.0104 1 1
Trypanosoma cruzi mitochondrial RNA binding complex 1 subunit, putative 0.0037 0 0.5
Trypanosoma cruzi Zn-finger in Ran binding protein and others, putative 0.0037 0 0.5
Plasmodium vivax hypothetical protein, conserved 0.0104 1 0.5
Trypanosoma cruzi WLM domain containing protein, putative 0.0037 0 0.5
Leishmania major hypothetical protein, conserved 0.0037 0 0.5
Brugia malayi SWIB/MDM2 domain containing protein 0.0104 1 1
Echinococcus multilocularis SWI:SNF matrix associated 0.0104 1 1
Trypanosoma brucei Zn-finger in Ran binding protein and others/FYVE zinc finger, putative 0.0037 0 0.5
Plasmodium vivax SWIB/MDM2 domain-containing protein, putative 0.0104 1 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0104 1 0.5
Chlamydia trachomatis DNA topoisomerase I 0.0104 1 0.5
Onchocerca volvulus 0.0104 1 1
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0104 1 1
Schistosoma mansoni hypothetical protein 0.0104 1 1
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0104 1 1
Brugia malayi brahma associated protein 60 kDa 0.0104 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.0037 0 0.5
Trypanosoma cruzi WLM domain containing protein, putative 0.0037 0 0.5
Chlamydia trachomatis SWIB complex protein 0.0104 1 0.5
Echinococcus multilocularis SWI:SNF matrix associated 0.0104 1 1
Leishmania major hypothetical protein, conserved 0.0037 0 0.5
Trypanosoma brucei hypothetical protein, conserved 0.0037 0 0.5
Echinococcus granulosus SWI:SNF matrix associated 0.0104 1 1
Leishmania major hypothetical protein, conserved 0.0037 0 0.5
Trypanosoma brucei mitochondrial RNA binding complex 1 subunit 0.0037 0 0.5
Trypanosoma cruzi Zn-finger in Ran binding protein and others/FYVE zinc finger, putative 0.0037 0 0.5
Toxoplasma gondii SWIB/MDM2 domain-containing protein 0.0104 1 1
Leishmania major hypothetical protein, conserved 0.0037 0 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0037 0 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0037 0 0.5
Trypanosoma brucei hypothetical protein, conserved 0.0037 0 0.5
Toxoplasma gondii DNA topoisomerase domain-containing protein 0.0104 1 1
Trypanosoma cruzi mitochondrial RNA binding complex 1 subunit, putative 0.0037 0 0.5
Echinococcus multilocularis Upstream activation factor subunit UAF30 0.0104 1 1
Schistosoma mansoni brg-1 associated factor 0.0104 1 1
Loa Loa (eye worm) brahma associated protein 0.0104 1 1
Leishmania major hypothetical protein, conserved 0.0037 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 0.2818 uM PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 10.4179 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (binding) = 28.1838 um PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] ChEMBL. No reference
Potency (functional) 39.8107 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.